PBM — Psyence Biomedical Cashflow Statement
0.000.00%
Last trade - 00:00- $8.21m
- $9.73m
Annual cashflow statement for Psyence Biomedical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | 10-K | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | 8.23 | 8.01 |
| Non-Cash Items | -8.56 | -8.48 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -0.505 | -0.054 |
| Change in Accounts Receivable | ||
| Change in Prepaid Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Cash from Operating Activities | -0.839 | -0.52 |
| Other Investing Cash Flow Items | -255 | — |
| Purchase of Investments | ||
| Cash from Investing Activities | -255 | — |
| Financing Cash Flow Items | -1.15 | 0 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 256 | 0 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 0.648 | -0.52 |